Sprint Bioscience AB (publ) (STO:SPRINT)
3.680
-0.120 (-3.16%)
Nov 20, 2026, 5:29 PM CET
| Market Cap | 388.30M +433.3% |
| Revenue (ttm) | 134.13M +168.1% |
| Net Income | 69.91M |
| EPS | 0.65 |
| Shares Out | 105.52M |
| PE Ratio | 5.66 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 195,798 |
| Open | 3.950 |
| Previous Close | 3.800 |
| Day's Range | 3.570 - 3.950 |
| 52-Week Range | 0.578 - 4.590 |
| Beta | -0.63 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Feb 11, 2027 |